GSK says Q3 earnings fall 14.4% amid COVID-19 disruption

LONDON (AP) – Drugmaker GlaxoSmithKline says third-quarter earnings fell 14.4% as disruptions caused by the COVID-19 pandemic reduced sales of vaccines, antibiotics and consumer healthcare products.

Read more…

Please follow and like us: